chr7-66086795-G-A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000048.4(ASL):​c.576G>A​(p.Lys192Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00116 in 1,588,272 control chromosomes in the GnomAD database, including 22 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0065 ( 14 hom., cov: 33)
Exomes 𝑓: 0.00060 ( 8 hom. )

Consequence

ASL
NM_000048.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.00100

Publications

1 publications found
Variant links:
Genes affected
ASL (HGNC:746): (argininosuccinate lyase) This gene encodes a member of the lyase 1 family. The encoded protein forms a cytosolic homotetramer and primarily catalyzes the reversible hydrolytic cleavage of argininosuccinate into arginine and fumarate, an essential step in the liver in detoxifying ammonia via the urea cycle. Mutations in this gene result in the autosomal recessive disorder argininosuccinic aciduria, or argininosuccinic acid lyase deficiency. A nontranscribed pseudogene is also located on the long arm of chromosome 22. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
ASL Gene-Disease associations (from GenCC):
  • argininosuccinic aciduria
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women’s Health, G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 7-66086795-G-A is Benign according to our data. Variant chr7-66086795-G-A is described in ClinVar as Benign. ClinVar VariationId is 92363.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.001 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00652 (993/152268) while in subpopulation AFR AF = 0.0224 (931/41564). AF 95% confidence interval is 0.0212. There are 14 homozygotes in GnomAd4. There are 473 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 14 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000048.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ASL
NM_000048.4
MANE Select
c.576G>Ap.Lys192Lys
synonymous
Exon 8 of 17NP_000039.2
ASL
NM_001024943.2
c.576G>Ap.Lys192Lys
synonymous
Exon 7 of 16NP_001020114.1
ASL
NM_001024944.2
c.576G>Ap.Lys192Lys
synonymous
Exon 7 of 15NP_001020115.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ASL
ENST00000304874.14
TSL:1 MANE Select
c.576G>Ap.Lys192Lys
synonymous
Exon 8 of 17ENSP00000307188.9
ASL
ENST00000395332.8
TSL:1
c.576G>Ap.Lys192Lys
synonymous
Exon 7 of 16ENSP00000378741.3
ASL
ENST00000395331.4
TSL:5
c.576G>Ap.Lys192Lys
synonymous
Exon 7 of 15ENSP00000378740.3

Frequencies

GnomAD3 genomes
AF:
0.00649
AC:
988
AN:
152150
Hom.:
14
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0223
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00347
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00147
AC:
297
AN:
202682
AF XY:
0.000996
show subpopulations
Gnomad AFR exome
AF:
0.0219
Gnomad AMR exome
AF:
0.000693
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000227
Gnomad OTH exome
AF:
0.000576
GnomAD4 exome
AF:
0.000596
AC:
856
AN:
1436004
Hom.:
8
Cov.:
32
AF XY:
0.000525
AC XY:
374
AN XY:
712220
show subpopulations
African (AFR)
AF:
0.0221
AC:
731
AN:
33084
American (AMR)
AF:
0.000848
AC:
34
AN:
40096
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25574
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38484
South Asian (SAS)
AF:
0.0000240
AC:
2
AN:
83214
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50464
Middle Eastern (MID)
AF:
0.000873
AC:
5
AN:
5728
European-Non Finnish (NFE)
AF:
0.00000455
AC:
5
AN:
1099942
Other (OTH)
AF:
0.00133
AC:
79
AN:
59418
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
54
108
161
215
269
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00652
AC:
993
AN:
152268
Hom.:
14
Cov.:
33
AF XY:
0.00635
AC XY:
473
AN XY:
74454
show subpopulations
African (AFR)
AF:
0.0224
AC:
931
AN:
41564
American (AMR)
AF:
0.00347
AC:
53
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68008
Other (OTH)
AF:
0.00331
AC:
7
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
48
95
143
190
238
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00330
Hom.:
1
Bravo
AF:
0.00765
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 08, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Argininosuccinate lyase deficiency Benign:2
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Dec 02, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not specified Benign:1
Jan 22, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
7.0
DANN
Benign
0.82
PhyloP100
0.0010
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115468878; hg19: chr7-65551782; API